Microbiology and ImmunologyVolume 39, Issue 1 p. 1-9 ReviewFree Access Virus Activation by Host Proteinases. A Pivotal Role in the Spread of Infection, Tissue Tropism and Pathogenicity Yoshiyuki Nagai, Yoshiyuki Nagai Department of Viral Infection, Institute of Medical Science, University of Tokyo, Shirokanedai 4-6-1, Minato-ku, Tokyo, 108 JapanSearch for more papers by this author Yoshiyuki Nagai, Yoshiyuki Nagai Department of Viral Infection, Institute of Medical Science, University of Tokyo, Shirokanedai 4-6-1, Minato-ku, Tokyo, 108 JapanSearch for more papers by this author First published: January 1995 https://doi.org/10.1111/j.1348-0421.1995.tb02161.xCitations: 35AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abbreviations FX blood clotting factor X HIV-1 human immunodeficiency virus type 1 NDV Newcastle disease virus PC proprotein convertase PIV3 parainfluenza virus 3 RSV respiratory syncytial virus VAP virus-activating proteinase. References 1Akaike, T., Molla, A., Ando, M., Araki, S., and Maeda, H. 1989. Molecular mechanism of complex infection by bacteria and virus analyzed by a model using serratial proteinase and influenza virus in mice. J. Virol. 63: 2252– 2259. CASPubMedWeb of Science®Google Scholar 2Barr, P.J. 1991. Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell 66: 1– 3. CrossrefCASPubMedWeb of Science®Google Scholar 3Blandford, G. 1975. Studies on the immune response and pathogenesis of Sendai virus infection of mice. III. The effects of cyclophosphamide. Immunology 28: 871– 883. CASPubMedWeb of Science®Google Scholar 4Bosch, V., and Pawlita, M. 1990. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J. Virol. 64: 2337– 2344. CASPubMedWeb of Science®Google Scholar 5Buckland, R., and Wild, F. 1989. Leucine zipper motif extends. Nature 338: 547. CrossrefCASPubMedWeb of Science®Google Scholar 6Chambers, P., Pringle, C.R., and Easton, A.J. 1990. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoprotein. J. Gen. Virol. 71: 3075– 3080. CrossrefCASPubMedWeb of Science®Google Scholar 7Gething, M.J., White, J.M., and Waterfield, M.D. 1978. Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc. Natl. Acad. Sci. U.S.A. 75: 2737– 2740. CrossrefCASPubMedWeb of Science®Google Scholar 8Gotoh, B., Ogasawara, T., Toyoda, T., Inocencio, N.M., Hamaguchi, M., and Nagai, Y. 1990. An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J. 9: 4189– 4195. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 9Gotoh, B., Ohnishi, Y., Inocencio, N.M., Esaki, E., Nakayama, K., Barr, P.J., Thomas, G., and Nagai, Y. 1992. Mammalian subtilisin-related proteinases in cleavage activating of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J. Virol. 66: 6391– 6397. CASPubMedWeb of Science®Google Scholar 10Gotoh, B., Yamauchi, F., Ogasawara, T., and Nagai, Y. 1992. Isolation of factor Xa from chick embryo as the amniotic endoprotease responsible for paramyxovirus activation. FEBS Lett. 296: 274– 278. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 11Gross, P.A., Green, R.H., and Curnen, M.G.M. 1973. Persistent infection with parainfluenza type 3 virus in man. Am. Rev. Resp. Dis. 108: 894– 898. CASPubMedWeb of Science®Google Scholar 12Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.-D., and Garten, W. 1992. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp 160 by specific peptidyl-chloromethyl ketones. Nature 360: 358– 361. CrossrefCASPubMedWeb of Science®Google Scholar 13Hatsuzawa, K., Murakami, K., and Nakayama, K. 1992. Molecular and enzymatic properties of furin, a Kex2 like endoprotease involved in precursor cleavage at Arg-X-Lys/Arrg-Arg sites. J. Biochem. 111: 296– 301. CrossrefCASPubMedWeb of Science®Google Scholar 14Homma, M., and Ohuchi, M. 1973. Trypsin action on the growth of Sendai virus in tissue culture cells. III. Structural difference of Sendai viruses grown in eggs and tissue culture cells. J. Virol. 12: 1457– 1465. CASPubMedWeb of Science®Google Scholar 15Hosaka, M., Nagahama, M., Kim, W.-S., Watanabe, T., Hatsuzawa, K., Ikemizu, J., Murakami, K., and Nakayama, K. 1991. Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. J. Biol. Chem. 266: 12127– 12130. CASPubMedWeb of Science®Google Scholar 16Iwata, S., Schmidt, A.C., Titani, K., Suzuki, M., Kido, H., Gotoh, B., Hamaguchi, M., and Nagai, Y. 1994. Assignment of disulfide bridges in the fusion glycoprotein of Sendai virus. J. Virol. 68: 3200– 3206. CASPubMedWeb of Science®Google Scholar 17Johnson, D.P., and Green, R.H. 1973. Viremia during parainfluenza type 3 virus infection of hamsters. Proc. Soc. Exp. Biol. Med. 144: 745– 748. CrossrefCASPubMedWeb of Science®Google Scholar 18Johnson, R.A., Prince, G.A., Suffin, S.C., Horswood, R.L., and Chanock, R.M. 1982. Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats. Infect. Immun. 37: 369– 373. CASPubMedWeb of Science®Google Scholar 19Julius, D.A., Brake, A., Blair, L., Kunisawa, R., and Thorner, J. 1984. Isolation of the putative structural gene for the lysine-arginine cleaving endopeptidase required for processing of yeast prepro-α-factor. Cell 37: 1075– 1089. CrossrefCASPubMedWeb of Science®Google Scholar 20Kawaoka, Y., Naeve, C.W., and Webster, R.G. 1984. Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from hemagglutinin? Virology 139: 306– 316. Google Scholar 21Kettner, C., and Shaw, E. 1981. The selective affinity labeling of factor X by peptides of arginine chloromethyl ketone. Thromb. Res. 22: 645– 652. CrossrefCASPubMedWeb of Science®Google Scholar 22Kido, H., Kamoshita, K., Fukutomi, A., and Katunuma, N. 1993. Processing protease for gp160 human immunodeficiency virus type I envelope glycoprotein precursor in human T4+ lymphocytes. J. Biol. Chem. 268: 13406– 13413. CASPubMedWeb of Science®Google Scholar 23Kido, H., Sakai, K., Kishino, Y., and Tashiro, M. 1993. Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus FEBS Lett. 32: 115– 119. Google Scholar 24Kido, H., Yokogoshi, Y., Sakai, K., Tashiro, M., Kishino, Y., Fukutomi, A., and Katunuma, N. 1992. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells: a possible activator of the viral fusion glycoprotein. J. Biol. Chem. 267: 13573– 13579. CASPubMedWeb of Science®Google Scholar 25Klenk, H.-D., and Garten, W. 1994. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 2: 39– 43. CrossrefCASPubMedGoogle Scholar 26Lazarowitz, S.G., Goldberg, A.R., and Choppin, P.W. 1973. Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen. Virology 56: 172– 180. CrossrefCASPubMedWeb of Science®Google Scholar 27McCune, J.M., Rabin, L.B., Feinberg, M.B., Lieberman, M., Kosek, J.C., Reyes, G.R., and Weissman, I.L. 1988. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53: 55– 67. CrossrefCASPubMedWeb of Science®Google Scholar 28Moehring, J.M., Inocencio, N.M., Robertson, B.J., and Moehring, T.J. 1993. Expression of mouse furin in a Chinese hamster cell resistant to pseudomonas exotoxin A and viruses complements the genetic lesion. J. Biol. Chem. 288: 2590– 2594. Google Scholar 29Mondino, A., Giordano, S., and Comoglio, P.M. 1991. Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor). Mol. Cell. Biol. 11: 6084– 6092. CrossrefCASPubMedWeb of Science®Google Scholar 30Morikawa, Y., Barsov, E., and Jones, I. 1993. Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin. J. Virol. 67: 3601– 3604. CASPubMedWeb of Science®Google Scholar 31Morrison, T.G., Ward, L.J., and Semerjian, A. 1989. Intra-cellular processing of the Newcastle disease virus fusion glycoprotein. J. Virol. 53: 851– 857. PubMedWeb of Science®Google Scholar 32Nagai, Y. 1993. Protease-dependent virus tropism and pathogenicity. Trends Microbiol. 1: 81– 87. CrossrefCASPubMedGoogle Scholar 33Nagai, Y., Inocencio, N.M., and Gotoh, B. 1991. Paramyxovirus tropism dependent on host proteases activating the viral fusion glycoprotein. Behring Inst. Mit. 89: 35– 45. CASGoogle Scholar 34Nagai, Y., and Klenk, H.-D. 1977. Activation of precursors to both glycoproteins of Newcastle disease virus by proteolytic cleavage. Virology 77: 125– 134. CrossrefCASPubMedWeb of Science®Google Scholar 35Nagai, Y., Klenk, H.-D., and Rott, R. 1976. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72: 494– 508. CrossrefCASPubMedWeb of Science®Google Scholar 36Nagai, Y., Ogura, H., and Klenk, H.-D. 1976. Studies on the assembly of the envelope of Newcastle disease virus. Virology 69: 523– 538. CrossrefCASPubMedWeb of Science®Google Scholar 37Nagai, Y., Shimokata, K., Yoshida, T., Hamaguchi, M., Iinuma, M., Maeno, K., Matsumoto, T., Klenk, H.-D., and Rott, R. 1979. The spread of a pathogenic and an apathogenic strain of Newcastle disease virus in the chick embryo as depending on the protease sensitivity of the virus glycoproteins. J. Gen. Virol. 45: 263– 272. CrossrefCASPubMedWeb of Science®Google Scholar 38Neyt, C., Geliebter, J., Slaoui, M., Morales, D., Meulemans, G., and Burny, A. 1989. Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies. J. Virol. 63: 952– 954. CASPubMedWeb of Science®Google Scholar 39Ogasawara, T., Gotoh, B., Suzuki, H., Asaka, J., Shimokata, K., Rott, R., and Nagai, Y. 1992. Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. EMBO J. 11: 467– 472. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 40Ohnishi, Y., Shioda, T., Nakayama, K., Iwata, S., Gotoh, B., Hamaguchi, M., and Nagai, Y. 1994. A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. J. Virol. 68: 4075– 4079. CASPubMedWeb of Science®Google Scholar 41Ortmann, D., Ohuchi, M., Angliker, H., Shaw, E., Garten, W., and Klenk, H.-D. 1994. Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2. J. Virol. 68: 2772– 2776. CrossrefCASPubMedWeb of Science®Google Scholar 42Sakaguchi, T., Fujii, Y., Kiyotani, K., and Yoshida, T. 1994. Correlation of proteolytic cleavage of paramyxovirus F protein precursors with expression of the fur, PACE4 and PC6 genes in mammalian cells. J. Gen. Virol. in press. Google Scholar 43Scheid, A., and Choppin, P.W. 1974. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57: 475– 490. CrossrefCASPubMedWeb of Science®Google Scholar 44Siezen, R.J., Creemers, J.W.M., and Van De Ven, W.J.M. 1994. Homology modelling of the catalytic domain of human furin. A model for the eukaryotic subtilisin-like proprotein convertases. Eur. J. Biochem. 222: 255– 266. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 45Steineke-Gröber, A., Vey, M., Angliker, H., Shaw, E., Thomas, G., Roberts, C., Klenk, H.-D., and Garten, W. 1992. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11: 2407– 2414. PubMedWeb of Science®Google Scholar 46Suzuki, H., Harada, A., Hayashi, Y., Wada, K., Asaka, J., Gotoh, B., Ogasawara, T., and Nagai, Y. 1991. Primary structure of the virus activating protease from chick embryo. Its identity with the blood clotting factor Xa. FEBS Lett. 283: 281– 285. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 47Takahashi, S., Kasai, K., Hatsuzawa, K., Kitamura, N., Misumi, Y., Ikehara, Y., Murakami, K., and Nakayama, K. 1993. A mutation of furin causes the lack of precursor-processing activity in human colon carcinoma LoVo cells. Biochem. Biophys. Res. Commun. 195: 1019– 1026. CrossrefCASPubMedWeb of Science®Google Scholar 48Tashiro, M., Ciborowski, P., Klenk, H.-D., Pulverer, G., and Rott, R. 1987. Role of staphylococcus protease in the development of influenza pneumonia. Nature 325: 536– 537. CrossrefCASPubMedWeb of Science®Google Scholar 49Tashiro, M., and Homma, M. 1983. Pneumotropism of Sendai virus in relation to protease mediated activation in mouse lung. Infect. Immun. 39: 879– 888. CASPubMedWeb of Science®Google Scholar 50Tashiro, M., and Homma, M. 1985. Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2. J. Virol. 53: 228– 234. CASPubMedWeb of Science®Google Scholar 51Tashiro, M., Yokogoshi, Y., Tobita, K., Seto, J.T., Rott, R., and Kido, H. 1992. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity. J. Virol. 66: 7211– 7216. CASPubMedWeb of Science®Google Scholar 52Toyoda, T., Gotoh, B., Sakaguchi, T., Kida, H., and Nagai, Y. 1988. Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. J. Virol. 62: 4427– 4430. CASPubMedWeb of Science®Google Scholar 53Toyoda, T., Sakaguchi, T., Hirota, H., Gotoh, B., Kuma, K., Miyata, T., and Nagai, Y. 1989. Newcastle disease virus evolution. II. Lack of gene recombination in generating virulent and avirulent strains. Virology 169: 273– 282. CrossrefCASPubMedWeb of Science®Google Scholar 54Toyoda, T., Sakaguchi, T., Imai, K., Inocencio, N.M., Gotoh, B., Hamaguchi, M., and Nagai, Y. 1987. Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology 158: 242– 247. CrossrefCASPubMedWeb of Science®Google Scholar 55van den Ouweland, A.M.W., van Duijnhoven, H.L.P., Keizer, G.D., Dorssers, L.C.J., and Van de Ven, W.J.M. 1990. Structural homology between the human fur gene product and the subtilisin-like protease encoded by yeast KEX2. Nucleic Acids Res. 18: 664. CrossrefCASPubMedWeb of Science®Google Scholar Citing Literature Volume39, Issue1January 1995Pages 1-9 ReferencesRelatedInformation
No takes yet. Share an insight, caveat, or question.
Yoshiyuki Nagai (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: